Clinical trial
DIALysis With EXpanded Solute Removal (DIALEX): A Large, Simple Randomized Trial to Evaluate the Major Health Effects of Expanded Versus Conventional Hemodialysis.
NCT06660277 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DIALysis With EXpanded Solute Removal (DIALEX): A Large, Simple Randomized Trial to Evaluate the Major Health Effects of Expanded Versus Conventional Hemodialysis.
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 12, 2025
- Completion date
- April 30, 2031
- Enrollment
- 4,800 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease requiring chronic dialysis, chronic kidney disease requiring hemodialysis, end-stage kidney disease (eskd), hemodialysis, kidney disease, kidney failure, chronic, pragmatic randomized controlled trial, renal insufficiency, chronic